H.R. 1285 · 113th Congress
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 113th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
BuchananSponsor54 cosponsors · 22 D, 32 R
D
Brown
DB
R
Benishek
DB
R
Black
JC
D
Cooper
AC
R
Crenshaw
SC
R
Capito
KC
D
Castor
JD
R
Duncan
MD
R
Diaz-Balart
TD
D
Deutch
SD
R
DesJarlais
RD
R
Davis
DE
D
Edwards
SF
R
Fincher
AH
D
Hastings
BH
D
Higgins
DI
R
Issa
WK
D
Keating
JK
D
Kennedy
SL
D
Lynch
EM
D
Markey
JM
R
Mica
JM
R
Miller
CM
R
Miller
TM
R
Marino
PM
D
Murphy
RN
R
Nugent
SP
R
Pearce
BP
R
Posey
NR
D
Rahall
HR
R
Rogers
IR
R
Ros-Lehtinen
PR
R
Roe
TR
R
Rooney
DR
R
Ross
LS
D
Slaughter
BS
R
Shuster
AS
R
Schock
SS
R
Southerland
SS
R
Stivers
PT
R
Tiberi
ST
R
Tipton
LW
R
Westmoreland
FW
D
Wilson
DC
R
Camp
JG
D
Garcia
CM
D
McCarthy
CR
D
Rangel
FW
R
Wolf
TY
R
Young
DL
D
Lipinski
JS
D
Schakowsky
ES
D
Swalwell
MC
D
Cartwright44 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.
What it does: CRS summary · Introduced in House · Mar 20, 2013
Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.
Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act.
Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Latest action (Apr 15, 2013): Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.
Policy area: Crime and Law Enforcement · Origin: House · Introduced: Mar 20, 2013
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.